Handelsinvest Investeringsforvaltning Mirati Therapeutics, Inc. Transaction History

Handelsinvest Investeringsforvaltning

  • $208 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024
BUY
$41.99 - $62.38 $130,588 - $194,001
3,110 New
3,110 $183,000
Q2 2021

Aug 10, 2021
SELL
$144.0 - $179.73 $2.16 Million - $2.7 Million
-15,000 Closed
0 $0
Q1 2021

Apr 20, 2021
BUY
$158.92 - $221.61 $397,299 - $554,025
2,500 Added 20.0%
15,000 $2.57 Million
Q3 2020

Oct 26, 2020
BUY
$113.26 - $167.27 $1.42 Million - $2.09 Million
12,500 New
12,500 $2.08 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Handelsinvest Investeringsforvaltning Portfolio

Follow Handelsinvest Investeringsforvaltning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

News

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email